Investment firm NovaQuest Private Equity agreed to acquire CoreRx, a global contract development and manufacturing organization. Financial terms were not disclosed. "This transaction is an endorsement of CoreRx’s success to date and its potential for future growth with NovaQuest, a firm with deep healthcare and life sciences expertise and a long history of partnering with market-leading businesses to take them to the next level. NovaQuest’s expertise in pharmaceutical services and enabling technologies will be invaluable as we look to further grow and enhance the value of our business in partnership with our customers," Todd R. Daviau, CoreRx President and CEO.